HomeMy WebLinkAboutContract 54388 DocuSign Envelope ID:F2C4EE94-DDC2-4EA4-94F2-76EC8E1 BE240
CSC No. 54388
Trusted Supplier Services Order Form
Trusted Supplier: Virta Health Accolade: Accolade,Inc.
Bri Treece 660 West Germantown Pike,Suite 500
501 Folsom Street Plymouth Meeting,PA 19462
San Francisco CA 94105 Attn:Robert Cavanaugh,President
bri.treece@virtahealth.com Copy to:Legal Department(legal@accolade.com)
Customer: City of Fort Worth
Joanne Hinton,CEBS
Benefits Manager
200 Texas Street,Fort Worth TX 76102
Telephone Number
Joanne.Hinton@fortworthtexas.gov
Trusted Supplier agrees to provide the services as further described in this"Order Form"to each Customer(as listed above)that orders the Services
specified in this Trusted Supplier Services Order Form, or any addenda hereto, and subject to the Trusted Supplier Program Terms (executed
separately and incorporated by reference),as supplemented by applicable supporting documentation. Trusted Supplier,Accolade and/or Customer
will also execute a Business Associate Agreement(BAA)in accordance with HIPAA(incorporated by reference herein). This Order Form,along with
the Trusted Supplier Program Terms, BAA, and any other exhibits or schedules attached hereto and incorporated by reference form a binding
agreement between the above-referenced Parties(collectively,"Order Form"). All capitalized terms not defined in this Form shall have the meaning
set forth in the Trusted Supplier Program Terms.
The Effective Date of this Order Form and the Trusted Supplier Program Terms is August 6,2020.
SERVICES ORDERED
[VIRTA/DIABETES REVERSAL FOR TYPE 2 Rates'
X Nutritional counseling,diabetes/pre-diabetes management and support,and medical $225 PPPM for the first 12 months of service for
care via a secure telehealth platform. each enrolled participant
$175 PPPPM starting in the 13th month of service
for each enrolled participant
❑ [Service Component 2]
❑Implementation Services(if any)
❑Other Services(if any)
Target Launch Date 10/1/2020
Initial Term 38 months from the actual Launch Date of the
Services
7,890
Estimated#of Eligible Employees Eligible population characteristics:Age 18-79 with
Type 2 Diabetes Diagnosis
'PPPM=Per Enrolled Participant Per Month,except as indicated.
SERVICE FEES
$225 PPPM for the first 12 months of service for each enrolled participant
Total Services Fee Rate:
$175 PPPPM starting in the 13th month of service for each enrolled participant
Performance Guarantees(if See Appendix B:Performance Guarantees
anY) 100%fees at risk tied to:Rx cost reduction,weight,A1c
Per Member/Employee Rates Rates fixed for the initial term. Following the initial term,rates may be increased by no more than 3%once
AnnualAdjustment every 12 months. Rate increases effective on the anniversary of the Launch Date.
OFFICIAL RECORD
CITY SECRETARY
FT. WORTH, TX
DocuSign Envelope ID:F2C4EE94-DDC2-4EA4-94F2-76EC8E1BE240
INVOICING
Invoice Cycle
Implementation Fee: Invoiced upon signing of contract and payable within thirty(30)days.
Invoicing Period: Accolade will handle Customer invoicing.
Fee Calculation:
For each month during the Term,the monthly fee shall be calculated as the sum of:
(a) $225 PPPM multiplied by the number of enrolled participants in their first 12 months of service,
and
(b) $175 PPPM multiplied by the number of enrolled participants in their 13th or higher month of
service
Fee True-Up: If payments are to be made on an advance basis,then within forty-five(45)days after the end of each
Invoicing Period,Accolade will calculate and submit an invoice for any under-or over-payments for the
prior Invoicing Period and Performance Guarantee amounts,if any,based on actual data,and deliver a
"True-Up Invoice"to Customer. Performance Guarantee calculations will be performed as set forth in
Appendix A to this Order Form. If an amount is owed by Customer for an underpayment,Accolade shall
collect such amounts in accordance with the payment terms set forth above. Any amounts over-paid
by Customer will be credited by Accolade in subsequent invoices against future amounts owed.
Final Accounting: Upon termination or expiration of this Order Form for any reason,Accolade shall prepare a final True-
Up Invoice using the methodology set forth above in the Fee True-Up section and determine the final
net amount owed by Customer to be reflected in a final invoice.
Invoicing;Payment Invoices will set forth on an itemized basis the amounts due and how such amounts are calculated based
Generally on the Employee count, Base Rates, Additional Services Rates and any applicable Performance
Guarantee amounts. Payments will be collected in United States dollars. Accolade will use reasonable
efforts to timely collect such payments,but shall not be liable for amounts not actually collected.
ADDITIONAL TERMS
Notwithstanding anything to the contrary herein (including any attached Exhibits),Accolade,Customer,and Trusted Supplier
agree to the followings additional terms and conditions. If any provisions of the Order Form,conflict with the terms hereunder,
are prohibited by applicable law,conflict with any applicable rule, regulation or ordinance of Customer,the terms in these
Terms and Conditions shall control.
Terms and Conditions
1. Termination
a. Fiscal Funding Out. In the event no funds or insufficient funds are appropriated by Customer in any fiscal
period for any payments due hereunder,Customer will notify Accolade,and Accolade shall notify Trusted
Supplier,of such occurrence and this Order Form shall terminate on the last day of the fiscal period for which
appropriations were received without penalty or expense to the Customer of any kind whatsoever,except as
to the portions of the payments herein agreed upon for which funds have been appropriated.
b. Duties and Obligations of the Parties. In the event that the Order Form is terminated prior to the end of the
then-current Term,Accolade shall pay Trusted Supplier for services actually rendered up to the effective date
of termination and Trusted Supplier shall continue to provide Customer with services requested by Customer
and in accordance with the Order Form up to the effective date of termination. Upon termination of the
Order Form for any reason,Trusted Supplier shall provide Customer with copies of all completed or partially
completed documents prepared under the Order Form. In the event Trusted Supplier has received access to
Customer information or data as a requirement to perform services hereunder,Trusted Supplier shall return
all Customer provided data to Customer in a machine readable format or other format deemed acceptable to
Customer.
DocuSign Envelope ID:F2C4EE94-DDC2-4EA4-94F2-76EC8E1BE240
2. Attorneys' Fees. Penalties,and Liquidated Damages. To the extent the attached Order Form require Customer to pay
attorneys'fees for any action contemplated or taken,or liquidated damages in any amount, Customer objects to
these terms and any such terms are hereby deleted from the Order Form and shall have no force or effect.
3. Law and Venue.The Order Form and the rights and obligations of the parties hereto shall be governed by,and
construed in accordance with the laws of the United States and state of Texas,exclusive of conflicts of laws provisions.
Venue for any suit brought under the Agreement shall be in a court of competent jurisdiction in Tarrant County,Texas.
To the extent the Agreement is required to be governed by any state law other than Texas or venue in Tarrant County,
Customer objects to such terms and any such terms are hereby deleted from the Agreement and shall have no force
or effect.
4. Linked Terms and Conditions. If the Order Form contains a website link to terms and conditions,the linked terms and
conditions located at that website link as of the Effective Date of the Order Form shall be the linked terms and
conditions referred to in the Order Form.To the extent that the linked terms and conditions conflict with any
provision of either these terms and conditions, or the Order Form,the provisions contained within these terms and
conditions and the Order Form shall control. If any changes are made to the linked terms and conditions after the date
of the Order Form,such changes are hereby deleted and void. Further,if Trusted Supplier cannot clearly and
sufficiently demonstrate the exact terms and conditions as of the Effective Date of the Order Form,all of the linked
terms and conditions are hereby deleted and void.
5. Insurance.The Customer is a governmental entity under the laws of the state of Texas and pursuant to Chapter 2259
of the Texas Government Code,entitled"Self-Insurance by Governmental Units,"is self-insured and therefore is not
required to purchase insurance.To the extent the Order Form requires Customer to purchase insurance,Customer
objects to any such provision,the parties agree that any such requirement shall be null and void and is hereby deleted
from the Order Form and shall have no force or effect. Customer may provide a letter of self-insured status as
requested by Accolade.
6. Sovereign Immunity. Nothing herein constitutes a waiver of the Customer's sovereign immunity.To the extent the
Order Form requires Customer to waive its rights or immunities as a government entity;such provisions are hereby
deleted and shall have no force or effect.
7. Indemnity. To the extent the Order Form,in any way, requires Customer to indemnify or hold Trusted Supplier or any
third party harmless from damages of any kind or character,Customer objects to these terms and any such terms are
hereby deleted from the Agreement and shall have no force or effect.
8. Public Information. Customer is a government entity under the laws of the State of Texas and all documents held or
maintained by Customer are subject to disclosure under the Texas Public Information Act.To the extent the
Agreement requires that Customer maintain records in violation of the Act,Customer hereby objects to such
provisions and such provisions are hereby deleted from the Agreement and shall have no force or effect. In the event
there is a request for information marked Confidential or Proprietary, Customer shall promptly notify Trusted
Supplier. It will be the responsibility of Trusted Supplier to submit reasons objecting to disclosure.A determination on
whether such reasons are sufficient will not be decided by Customer, but by the Office of the Attorney General of the
State of Texas or by a court of competent jurisdiction.
9. Insurance.Trusted Supplier agrees that insurance coverage provided to Customer by Trusted Supplier is sufficient for
purposes of the Order Form.
10. No Debt. In compliance with Article 11§5 of the Texas Constitution,it is understood and agreed that all obligations of
Customer hereunder are subject to the availability of funds. If such funds are not appropriated or become unavailable,
Customer shall have the right to terminate the Order Form except for those portions of funds which have been
appropriated prior to termination.
11. Immigration Nationality Act. Trusted Supplier shall verify the identity and employment eligibility of its employees who
perform work under the Agreement,including completing the Employment Eligibility Verification Form(1-9). Trusted
Supplier shall adhere to all Federal and State laws as well as establish appropriate procedures and controls so that no
services will be performed by any Trusted Supplier employee who is not legally eligible to perform such services.
TRUSTED SUPPLIER SHALL INDEMNIFY CUSTOMER AND HOLD CUSTOMER HARMLESS FROM ANY THIRD PARTY
PENALTIES,LIABILITIES,OR LOSSES DUE TO VIOLATIONS OF THIS PARAGRAPH BY TRUSTED SUPPLIER,TRUSTED
SUPPLIER'S EMPLOYEES,SUBCONTRACTORS,AGENTS,OR LICENSEES.
12. No Boycott of Israel. If Trusted Supplier has fewer than 10 employees or the Order Form is for less than$100,000,this
section does not apply.Trusted Supplier acknowledges that in accordance with Chapter 2270 of the Texas
Government Code,Customer is prohibited from entering into a contract with a company for goods or services unless
the contract contains a written verification from the company that it:(1)does not boycott Israel;and (2)will not
boycott Israel during the term of the contract. The terms"boycott Israel"and "company"shall have the meanings
ascribed to those terms in Section 808.001 of the Texas Government Code. By signing this Order Form, Trusted
DocuSign Envelope ID:F2C4EE94-DDC2-4EA4-94F2-76EC8E1 BE240
Supplier certifies that Trusted Supplier's signature provides written verification to Customer that Trusted Supplier:(1)
does not boycott Israel;and(2)will not boycott Israel during the term of the Order Form.
13. Right to Audit. Trusted Supplier agrees that Customer, no more than once per annum,shall,until the expiration of
three(3)years after final payment under this Order Form, have access to and the right to examine any directly
pertinent books,documents, papers and records of Trusted Supplier involving transactions relating to this Order Form.
Trusted Supplier agrees that Customer shall have access during normal business hours to all necessary Trusted
Supplier facilities and shall be provided adequate and appropriate workspace in order to conduct audits in compliance
with the provisions of this section.Customer shall give Accolade and Trusted Supplier reasonable advance notice, but
no less than ten(10) business days,of intended audits,and such audits shall be conducted during normal business
hours. If reasonably possible,inspections will be conducted on a documentary basis. If on-site inspections are
required,inspections shall be conducted during regular business hours and designed to mitigate disruption to Trusted
Supplier's normal business operations. Any personnel of the Customer or an independent auditor who will be on-site
at one of Trusted Supplier's locations must adhere to Trusted Supplier's policies and procedures. Independent
auditors will be required to execute a reasonable confidentiality agreement and,if such auditors will access,receive,
transmit,or store protected health information,they will be a"business associate"of the Customer.
SIGNATURES
This Order Form,along with the Trusted Supplier Program Terms,BAA,and any other exhibits or schedules attached hereto and
incorporated by reference constitutes the entire agreement between the Parties with respect to the subject matter hereof,and
supersedes all other communications and all other prior understandings or agreements between the Parties with respect to such
subject matter hereof.
EXECUTED as of August 6,2020 by the Parties hereto,each acting under due and proper authority.
ACCOLADE,INC. TRUSTED SUPPLIER
D U'ocu Signed by: F
oocuSilgned by:
By. � �ll�l�l By. U/U h t,
FG23ESA-54B ...
Name: Rajeev Singh Name: Trent Myers
Title: CEO Title: VP commercial
Date: 8/7/2020 Date: 8/6/2020
OFFICIAL RECORD
CITY SECRETARY
FT. WORTH, TX
DocuSign Envelope ID:F2C4EE94-DDC2-4EA4-94F2-76EC8E1 BE240
CUSTOMER:
City of Fort Worth Contract Compliance Manager:
By signing I acknowledge that I am the person
responsible for the monitoring and administration
of this contract, including ensuring all performance
By. CDocuSigned by: and reporting requirements.
—)PPF'rT385D'26832 _
Name: Jesus Chapa
Title: Assistant City Manager DocuSigned by:
By: FQaos
Name. Joanne Hinton
Date: 8/27/2020
Title: Benefits Manager
Approval Recommended:
Approved as to Form and Legality:
S
ocuSigned by
'N ^`
F� :
'(,(�,�, DocuSigned by:
By. - -o- F�66� �j, �fV'b�A
Name: Nathan Gregory By: D6CF7�21-C C _ "
Name: John B.Strong
Title: Assistant Director of Human Resour es
Title: Assistant City Attorney
Attest: �boF F coo.a
p__� °°�,�� Contract Authorization:
PVo o
M&C:
be o4ow 4q��
By:
Name: Mary Kayser
Title: City Secretary
OFFICIAL RECORD
CITY SECRETARY
FT. WORTH, TX
DocuSign Envelope ID:F2C4EE94-DDC2-4EA4-94F2-76EC8E1BE240
APPENDIX A
SERVICES DESCRIPTION
VIRTA SERVICES
Telemedicine - Provide nutritional counseling,diabetes management and support,and Medical Care
Services: (as defined in the Agreement)via a secure telemedicine platform.
Patient - Provide Patient starter kit to each Patient for the individualized treatment plan,which
Supplies: will include: body weight scale,precision xtra meter to measure glucose and ketones,
ketone and glucose test strips, lancets,alcohols swabs,protein scale,and blood
pressure cuff(if needed,as determined by a Virta Provider).
Account - Provide a designated Customer Success Manager that will be the relationship point of
Management: contact and manage the Customer's account. This individual will be available to
Customer by telephone during business hours 8:00 a.m. to 5:00 p.m., (pacific standard
time,Monday through Friday), and will be responsible for ensuring a successful
launch,and providing ongoing support,regular business reviews and strategic
recommendations to achieve Customer's success criteria.
Designated Marketing - Provide a designated marketing lead to share marketing best practices,create
Lead: marketing collateral and develop a marketing plan that will drive Covered Persons to
enroll in the Services.
- Provide Customer with a plan that outlines timelines and best practices for a successful
marketing launch.
Patient Labs: - Order Laboratory tests as required by Virta providers, at a frequency and at lab
facilities designated by Virta("Labs").
- Labs completed at non-Virta designated facilities will be paid for by the Patient or
Plan.
Patient EKG: - Order EKG tests as determined by a Virta Provider,or in their sole discretion,in
consultation with the Patient's primary care physician or cardiologist, at a frequency
and at facilities designated by Virta("EKGs").
- EKGs completed at non-Virta designated facilities will be paid for by the Patient or
Plan
DocuSign Envelope ID:F2C4EE94-DDC2-4EA4-94F2-76EC8E1BE240
Customer reporting: - Provide Customer with regular reporting that includes patient engagement and
satisfaction metrics, as well as deeper-dive reporting delivered in regular business
reviews that include:patient engagement and satisfaction,marketing channels'
performance, and recommendations to increase impact,clinical outcomes,and
economic outcomes. All reports are in a form consistent with both Parties' obligations
under HIPAA.
Implementation Plan: - Provide an implementation plan including,but not limited to:
o enrollment targets;
o key milestones,timelines and deliverables;
o key launch details, and success criteria;
o data exchange, and billing information;
o key contacts; and
0 outstanding question and action lists.
CUSTOMER DELIVERABLES
Account - Designate an individual to manage the relationship. This individual shall be available
Manager: to Virta for progress check-ins and by telephone during business hours.
Enrollment Assistance: - Provide Virta with required population data,channels,and marketing support for
communicating Virta to Covered Persons.
- Assist Virta in enrolling Covered Persons who meet the Eligibility Requirements(see
above), including whitelisting Virta emails for delivery to appropriate population.
Eligibility Data: - Provide demographic information,plus a unique identifier field,for Covered Persons,
in a file provided via secure transfer at a monthly frequency,as specified in Virta's
Standard Eligibility File Format Specification.
Covered Person - Provide information including email address,physical address,and phone number, as
Contact Data: available,paired with appropriate identifying information for each Covered Person.
This can be provided via the Eligibility File above.
Claims Data: - Provide monthly medical claims and pharmacy data for the period that is twelve(12)
months prior to the Effective Date for each Covered Person with the fields and format
as specified in Virta's Standard Claims Data Format Specification.
Data Exchange - Assist Virta with the set-up and ongoing data exchange with any third-party providing
with Customer data on behalf of Customer.
Subcontractor:
DocuSign Envelope ID:F2C4EE94-DDC2-4EA4-94F2-76EC8E1BE240
APPENDIX B
PERFORMANCE GUARANTEES
For any Performance Guarantee to be in effect during any Measurement Period there must be at least 25 Attributed
Patients for the calculation during the Measurement Period.Enrolled Patients that are not considered Attributed
Patients during any Measurement Period will be included in the next Measurement Period, as long as they are
considered Attributed Patients during that Measurement Period.
For purposes of clarity,the performance calculation may be based on all three components(HbAlc Reduction,
Weight Loss and DM Rx Cost Reduction), or the following two components: HbAIc Reduction and Weight Loss, as
mutually agreed upon by the parties.
DEFINITIONS
"Attributed Patient"shall mean a Patient enrolled in the Services for at least six(6)months during the applicable
Measurement Period,with at least one recorded Baseline HbAlc.
"Attributed Patient Months" shall mean the total cumulative number of months for which Patients are considered
Attributed Patients during the applicable Measurement Accounting Period.
"Baseline HbAlc" is a Patient's Valid HbAlc that is recorded prior to Virta accepting them from treatment into the
Services.
If no Baseline HbAIc is available for a Patient,such Patient will not be included in any performance guarantee calculations.
"Baseline Monthly Rx Claims Cost"is calculated by taking the average monthly Diabetes Specific Pharmacy Costs
for the four months prior to the Enrollment Date for all Attributed Patients. To adjust for price differences between
the Baseline and Measurement Period,Measurement Period unit prices for Outpatient DM Prescription Drugs are
used for both the Measurement Period and Baseline Period Monthly Rx Claims Costs. If there is no prior claims
history for an Attributed Patient,Baseline Monthly Rx Claims Cost will be estimated using: (i)the patient reported
medications during the Virta treatment intake call,and(ii)Customer specific costs for those medications.
"Baseline Weight"is a Patient's first weight measurement recorded by Virta after their Enrollment Date.
"Diabetes Specific Pharmacy Cost"means the sum of(i)the claims amount paid by Plan for Attributed Patients for
Outpatient DM Prescription Drugs and(ii)each such Attributed Patient's co-pay, co-insurance or other patient
responsibility amounts for such Outpatient DM Prescription Drugs.
"Outpatient DM Prescription Drugs"means those drugs set forth on Table 3 of this Exhibit.
"Performance Guarantees" are the clinical and financial targets outlined in Table 2. Each Performance Guarantee is
subject to a Refund during each Measurement Period as outlined in Table 2.
"Reconciliation"is the process after each Measurement Period of determining if any Refund is due based on achievement
or lack thereof of the Performance Guarantees outlined in Table 2.
DocuSign Envelope ID:F2C4EE94-DDC2-4EA4-94F2-76EC8E1BE240
"Reconciliation Period"is the period following the end of a Measurement Period in which the Reconciliation is completed.
For calculation of the DM Rx Cost Reduction Performance Guarantee, claims are required that were incurred during the
Measurement Period and paid anytime up to and including 90 days after the end of the Measurement Period. The
Reconciliation Period begins on the day Virta gets all the claims data necessary to calculate the Performance Guarantees.
Within 60 days after the beginning of the Reconciliation Period,Virta will deliver an analysis of the Performance Guarantees
to Customer. The Customer then has 60 days to accept the results and/or perform an audit of the results.Any Refund owed
to Customer by Virta will be paid within 90 days of the end of the Reconciliation Period.
"Refund" is any amount of money that Virta must return to Customer based on lack of achievement of the Performance
Guarantees during any Measurement Period as outlined in Table 2.
"Treatment HbAlc"is a Patient's Valid HbAlc measurement that is recorded during the period that is 30 days prior
to the end of the Measurement Period and 60 days after the Measurement Period.
"Treatment Monthly Rx Claims Cost"is the sum of Diabetes Specific Pharmacy Costs for all Attributed Patients
during the Measurement Period divided by total Attributed Patient Months for all Attributed Patients during the
Measurement Period.
"Treatment Period"is the 12-month period following the Launch Date and each subsequent 12-month period thereafter.
"Treatment Weight" is a Patient's weight that is recorded during the period that is 30 days prior to the end of the
Measurement Period and 60 days after the Measurement Period.
"Trend"means amount of cost increase experienced by the Plan for Outpatient DM Prescription Drugs between the
Baseline Monthly Rx Costs and the Measurement Period Monthly Rx Costs. Trend is calculated by taking the
weighted average cost increase(based on baseline period usage)for Outpatient DM Prescription Drugs.
"Valid HBAlc" is an HBAlc measurement that is recorded by (i) a qualified healthcare provider (lab and/or other
healthcare professional), (ii) through an FDA approved handheld HbA1C meter; or (iii) a patient-reported blood glucose
reading(s)taken from a from an FDA-approved meter,and using Virta's correlation/prediction algorithms where an HbAlc
cannot be obtained from(i)or(ii)above.
DocuSign Envelope ID:F2C4EE94-DDC2-4EA4-94F2-76EC8E1BE240
TABLE 2: PERFORMANCE TARGETS &REFUND STRUCTURE
dL HBA1C REDUCTION PERFORMANCE METRIC PERFORMANCE REFUND
TARGET DUE
Is calculated as: ([A] —[B])/ [C];where [A] =the sum of each Attributed 1 point reduction or
Patient's Treatment HBAlc, [B] =the sum of each Attributed Patient's Baseline better 0%
HBAlc, and[C] =the total number of Attributed Patients.
For example: if there are 5 Attributed Patients with Treatment HBAlc levels of 5, 0.99- .75 points 6.60%
6, 7, 8, and 9 and Baseline HBAIc levels of 7, 8, 9, 10 and 11:
[A] will equal [5+6+7+8+9] =35 .74- .49 points 13.20%
[B] will equal [7+8+9+10+11] =45 .48 - .23 points 19.80%
[C] equals [5]
22- .01 points 26.40%
HBAlc Reduction will equal([35]—[45])/[5] _-1.0 points,and Virta will not
owe Customer a Refund
0 points or worse 33.33%
WEIGHT LOSS PERFORMANCE METRIC PERFORMANCE REFUND
TARGET DUE
Is calculated as—(([A] —[B])/ [B]) * 100; where [A] =the sum of each 5.00%or better 0%
Attributed Patient's Treatment Weight,and[B] =the sum of each Attributed
Patient's Baseline Weight. 4.99 -3.00% 6.60%
For example: if there are 50 Attributed Patients each with an average Treatment
Weight of 200lbs and average Baseline Weight of 225lbs: 2.99 -2.00% 13.20%
[A] will equal [10,0001 (50*200)
1.99 - 1.00% 19.80%
[B] will equal [11,250] (50 *225)
The Weight Loss will equal([10,000]—[11,250])/[11,250] * 100= 11.1%,and •99- .01 % 26.40%
Virta will not owe Customer a Refund
0% or worse 33.33%
DocuSign Envelope ID:F2C4EE94-DDC2-4EA4-94F2-76EC8E1BE240
DM RX COST REDUCTION PERFORMANCE METRIC PERFORMANCE REFUND
TARGET DUE
Is calculated as—(([A]—[B])/ [B])*[1+C]*100; where [A] =the Treatment 40%or better 0%
Monthly Rx Claims Cost,and[B]=the Baseline Monthly Rx Claims Cost.And
[C] =Trend
39.99 -30.00% 6.60%
For example,if-
[A] equals $400 per Attributed Patient per month 29.99 -20.00% 13.20%
[B] equals$1,200 per Attributed Patient per month 19.99 - 10.00% 19.80%
[C] equals 6%
9.99 - .01% 26.40%
The DM Rx Cost reduction will be:
(($400-$1200)/$1200) * (1+0.06) * 100=70.67%and Virta will not owe
Customer a Refund
0% or worse 33.33%
TABLE 3: OUTPATIENT PRESCRIPTION DRUGS
Drug Class ff 7- Drug Sub Class
Dipeptidyl Peptidase-4 Inhibitor-Biguanide
Combinations
Dpp-4 Inhibitor-Thiazolidinedione Combinations
Insulin-Incretin Mimetic Combinations
Antidiabetic Combinations
Sglt2 Inhibitor-Dpp-4 Inhibitor Combinations
Sodium-Glucose Co-Transporter 2 Inhibitor-Biguanide
Comb
Thiazolidinedione-Biguanide Combinations
Dipeptidyl Peptidase-4(Dpp-4) Dipeptidyl Peptidase-4(Dpp-4)Inhibitors
Inhibitors
Incretin Mimetic Agents(Glp-1 Incretin Mimetic Agents(Glp-1 Receptor Agonists)
Receptor Agonists)
DocuSign Envelope ID:F2C4EE94-DDC2-4EA4-94F2-76EC8E1BE240
Insulin Human Insulin
Sodium-Glucose Co-Transporter 2 Sodium-Glucose Co-Transporter 2(Sglt2)Inhibitors
(Sglt2)Inhibitors
Insulin Administration Supplies
Diabetic Supplies
Glucose Monitoring Test Supplies
Antidiabetic Combinations Sulfonylurea-Biguanide Combinations
Biguanides Biguanides
Insulin Sensitizing Agents Thiazolidinediones
Sulfonylureas Sulfonylureas
Meglitinide Analogues Meglitinide Analogues